Play all audios:
Access through your institution Buy or subscribe Kim, S. _ et al_. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment. _Arthritis Rheum._ 60,
1825–1830 (2009). Sustained, complete remission of juvenile dermatomyositis (DM) could be achieved in just over 3 years of starting therapy using a protocol developed by researchers at The
Children's Hospital Boston. Despite advances in therapy, patients with juvenile DM remain at significant risk of long-term mortality. “Our personal experience led to the development of
a regimen to treat patients aggressively early in the course of the disease, with the goal of complete control of all detectable evidence of disease,” explains lead investigator Susan Kim.
This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access
$209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are
calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support Authors * Negin Nassabeh View author
publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Nassabeh, N. Sustaining
remission in juvenile dermatomyositis. _Nat Rev Rheumatol_ 5, 413 (2009). https://doi.org/10.1038/nrrheum.2009.123 Download citation * Issue Date: August 2009 * DOI:
https://doi.org/10.1038/nrrheum.2009.123 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not
currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative